NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00258310 Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo Status COMPLETED Phase PHASE2
NCT00256308 Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00248560 Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00245349 Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer Status COMPLETED Phase N/A
NCT00243113 Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx Status COMPLETED Phase PHASE2
NCT00242762 ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer Status COMPLETED Phase PHASE2
NCT00233636 Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck Status WITHDRAWN Phase PHASE2
NCT00230308 Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer Status RECRUITING Phase N/A
NCT00230295 Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast Status COMPLETED Phase NA
NCT00230269 The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers Status COMPLETED Phase N/A
NCT00230256 Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers Status COMPLETED Phase N/A
NCT00228488 Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma Status COMPLETED Phase PHASE2
NCT00216138 Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck Status TERMINATED Phase PHASE2
NCT00203905 A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck Status COMPLETED Phase PHASE2
NCT00198315 Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE3
NCT00198263 Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer Status COMPLETED Phase PHASE4